SteelPeak Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
SteelPeak Wealth's AMPH Position: Q3 2026 in Review
SteelPeak Wealth increased its Amphastar Pharmaceuticals (AMPH) stake by 0.05% in Q3 2026, buying an estimated $519 and bringing the position to 48,708 shares worth $1.26M. The position accounts for 0.03% of the portfolio, ranked #296.
SteelPeak Wealth first reported a position in AMPH in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.62M in Q1 2025. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- SteelPeak Wealth held 48,708 shares of Amphastar Pharmaceuticals worth $1.26M as of Q3 2026.
- SteelPeak Wealth bought 24 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $519.
- Amphastar Pharmaceuticals made up 0.03% of SteelPeak Wealth's portfolio in Q3 2026, its #296 holding.
- SteelPeak Wealth first reported a position in Amphastar Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- SteelPeak Wealth's Amphastar Pharmaceuticals position peaked at $1.62M in Q1 2025.
- 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on SteelPeak Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.